✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
patient with metastatic Ewing's sarcoma who developed encephalopathy after treatment with gemcitabine, and his rapid recovery after discontinuation of the drug.Key Words: Gemcitabine, Neurotoxicity, Pediatric cancer
📌 3 Key Takeaways
🎯
Objective & Hypothesis:patient with metastatic Ewing's sarcoma who developed encephalopathy after treatment with gemcitabine, and his rapid recovery after discontinuation of the drug.Key Words: Gemcitabine, Neurotoxicity, Pediatric cancer
📊
Key Findings & Data:patient with metastatic Ewing's sarcoma who developed encephalopathy after treatment with gemcitabine, and his rapid recovery after discontinuation of the drug.Key Words: Gemcitabine, Neurotoxicity, Pediatric cancer
💡
Conclusion & Impact:patient with metastatic Ewing's sarcoma who developed encephalopathy after treatment with gemcitabine, and his rapid recovery after discontinuation of the drug.Key Words: Gemcitabine, Neurotoxicity, Pediatric cancer
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
patient with metastatic Ewing's sarcoma who developed encephalopathy after treatment with gemcitabine, and his rapid recovery after discontinuation of the drug.Key Words: Gemcitabine, Neurotoxicity, Pediatric cancer
🔖
Cite This Article
BERRAK, S. G., SOYSAL, A., TÜRKKAN, E., CANPOLAT, C. (2002). GEMCITABINE-ASSOCIATED REVERSIBLE ENCEPHALOPATHY A CASE REPORT. Marmara Medical Journal, Cilt: 15 - Sayı: 3, 180–182. https://ajindex.com/articles/284173